Lada Rasochova

Lada Rasochova is the current CEO at Dermala. Lada has also previously worked as a judge for the Nokia Sensing XCHALLENGE from January 2014 to December 2016. Rasochova has made many innovative scientific contributions throughout their career. In 2006, 2007, and 2008, they were recognized as an Innovative Scientific Contributor by The Dow Chemical Company. Rasochova has also built and managed the Human Vaccine Division of the Dow Chemical Company. Additionally, they have led an R&D team of 20+ scientists and been a member of the Intellectual Capital Management Team. This experience has allowed their to develop IP strategy for human vaccines as well as identify new business opportunities in human vaccines. Furthermore, Rasochova has closed several multi-million dollar vaccine antigen production contracts with outside parties throughout their career.

Some direct reports include Alex Alim - CTO, Michelle Kem - COO.